成人新发脑炎ICU入住风险评分:开发与验证
该研究基于休斯顿两家医院372例符合IEC标准的脑炎患者(队列1)开发ICU入住风险评分,并在巴尔的摩两家医院独立队列(队列2,2006–2022年)进行外部验证。多因素分析显示,局灶神经体征、新发癫痫、FOUR评分≤14、白细胞增多、入院时慢性肾病史与ICU入住风险增加相关。风险评分在队列1的AUROC为0.77(95%CI 0.72–0.82,p<0.001),低风险(评分0)ICU入住率12.5%、中风险(评分1–5)49.5%、高风险(评分6–8)87.5%;在队列2外部验证AUROC为0.76(95%CI 0.69–0.83,p<0.001)。作者认为该评分涵盖神经与全身因素,可能有助于医生在成人脑炎患者入院时决定治疗强度。
要点
- 634例脑炎患者中255例(40%)入住ICU,自身免疫性病因45/113(39.8%)、感染性病因100/272(36.7%)、病因不明110/249(44.1%)(p=0.225)。
- 多因素分析显示,局灶神经体征、新发癫痫、FOUR评分≤14、白细胞增多、入院时慢性肾病史与ICU入住风险增加相关。
- 风险评分将患者分为低风险(评分0,ICU入住率12.5%)、中风险(评分1–5,49.5%)、高风险(评分6–8,87.5%)。
- 开发队列AUROC为0.77(95%CI 0.72–0.82,p<0.001),外部验证队列AUROC为0.76(95%CI 0.69–0.83,p<0.001)。
- 作者认为该评分可能有助于医生在成人脑炎患者入院时决定治疗强度。
适用人群与场景
- 成人脑炎患者,符合国际脑炎联盟(IEC)标准;开发队列来自休斯顿两家医院2005–2023年,验证队列来自巴尔的摩两家医院2006–2022年。
诊断标准与关键阈值
- 采用国际脑炎联盟(IEC)标准诊断脑炎。
- 风险评分低风险为评分0,中风险为评分1–5,高风险为评分6–8。
研究设计与关键结果
- 研究类型为风险评分开发与外部验证研究;开发队列372例,验证队列(队列2)来自巴尔的摩两家医院;总634例脑炎患者中255例(40%)入住ICU。
- 不同病因的ICU入住率:自身免疫性45/113(39.8%)、感染性100/272(36.7%)、病因不明110/249(44.1%),p=0.225。
- 多因素分析显示,局灶神经体征、新发癫痫、FOUR评分≤14、白细胞增多、入院时慢性肾病史与ICU入住风险增加相关。
- 风险评分在开发队列的AUROC为0.77(95%CI 0.72–0.82,p<0.001);低风险(评分0)ICU入住率12.5%,中风险(评分1–5)49.5%,高风险(评分6–8)87.5%。
- 外部验证队列AUROC为0.76(95%CI 0.69–0.83,p<0.001)。
证据类型、等级与局限
- 证据类型:风险评分开发与外部验证研究(队列研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,涵盖神经与全身因素的风险评分可能有助于医生在成人脑炎患者入院时决定治疗强度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Timely intensive care unit (ICU) admission for patients with encephalitis is associated with better prognosis. Therefore, our aim was to create a risk score predicting ICU admission in adults with encephalitis, which could aid in optimal management and resource allocation.
METHODS: We initially identified variables that would be most predictive of ICU admission among 372 patients with encephalitis from two hospital systems in Houston, Texas (cohort 1), who met the International Encephalitis Consortium (IEC) criteria from 2005 to 2023. Subsequently, we used a binary logistic regression model to create a risk score for ICU admission, which we then validated externally using a separate cohort of patients from two hospitals in Baltimore, Maryland (cohort 2), who met the IEC criteria from 2006 to 2022.
RESULTS: Of 634 patients with encephalitis, 255 (40%) were admitted to the ICU, including 45 of 113 (39.8%) patients with an autoimmune cause, 100 of 272 (36.7%) with an infectious cause, and 110 of 249 (44.1%) with an unknown cause (p = 0.225). After conducting a multivariate analysis in cohort 1, we found that the presence of focal neurological signs, new-onset seizure, a Full Outline of Unresponsiveness score ≤ 14, leukocytosis, and a history of chronic kidney disease at admission were associated with an increased risk of ICU admission. The resultant clinical score for predicting ICU admission had an area under the receiver operating characteristic curve (AUROC) of 0.77 (95% confidence interval [CI] 0.72-0.82, p < 0.001). Patients were classified into three risk categories for ICU admission: low risk (score 0, 12.5%), intermediate risk (scores 1-5, 49.5%), and high risk (scores 6-8, 87.5%). External validation in cohort 2 yielded an AUROC of 0.76 (95% CI 0.69-0.83, p < 0.001).
CONCLUSIONS: ICU admission is common in patients with encephalitis, regardless of etiology. Our risk score, encompassing neurologic and systemic factors, may aid physicians in decisions regarding intensity of care for adult patients with encephalitis upon hospital admission.
参考来源
- Habis R, Heck A, Bean P, et al. Development and Validation of a Risk Score for Predicting ICU Admission in Adults with New-Onset Encephalitis. Neurocrit Care. 2024. PMID: 39085505. doi:10.1007/s12028-024-02063-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。